Latest filing published 17 Jun 2014 for Lineage Cell Therapeutics, Inc., €6,618.
Insider track record
No signal scores available.
William P. Tew PhD: trading record in brief
All filings by William P. Tew PhD on record concern Lineage Cell Therapeutics, Inc. Between 18 November 2013 and 17 June 2014, the trades on record add up to 6 filings.
On the market, this insider has only sold: 6 sales, €106k in total. Since January 2014: no purchases and 3 sales on the market.
The latest filing, published on 17 June 2014, reports an open-market sale of €6,618 in Lineage Cell Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William P. Tew PhD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ US$2.99Common Shares, no par valueSEC:0001209191-14-042190:0
- 20,000 shares@ US$3.02Common Shares, no par valueSEC:0001209191-14-042190:1
- 7,000 shares@ US$3.23Common Shares, no par valueSEC:0001209191-14-042190:2
- 5,000 shares@ US$3.77Common Shares, no par valueSEC:0001209191-13-053451:0
- 5,000 shares@ US$3.76Common Shares, no par valueSEC:0001209191-13-053451:1
- 3,860 shares@ US$3.73Common Shares, no par valueSEC:0001209191-13-053451:2
6 of 6 declarations